Virtual trials in virtual patients. Is this how we will accelerate progress in personalised treatments?
If mind-boggling complexity is the barrier to developing personalised cancer care strategies, could mathematical modelling – long used by economists, meteorologists and others – be the answer? Marc Beishon talks to leading figures who are [more]